A patient with a complicated medical history including hypertension, a-fib, and arthritis calls the health care provider's office to speak with a nurse about "all of these bruises I have all of a sudden." Which potential drug interaction should concern the nurse with these symptoms?
Aspirin and warfarin
Sulfasalazine and acetaminophen
Tolmetin and propranolol
Meloxicam and amlodipine
The Correct Answer is A
A. Aspirin and warfarin
The combination of aspirin and warfarin poses a potential risk of increased bleeding and bruising. Both aspirin and warfarin are anticoagulants, and when used together, they can potentiate each other's effects, leading to a higher risk of bleeding events, including easy bruising.
B. Sulfasalazine and acetaminophen
Sulfasalazine is often used in the treatment of arthritis and inflammatory bowel disease, while acetaminophen is a commonly used pain reliever. There is no significant interaction between these two medications leading to increased bleeding or bruising.
C. Tolmetin and propranolol
Tolmetin is a nonsteroidal anti-inflammatory drug (NSAID) used for pain relief, and propranolol is a beta-blocker used for conditions such as hypertension. While both medications have their own potential side effects, there is no specific interaction between them that significantly increases the risk of bleeding or bruising.
D. Meloxicam and amlodipine
Meloxicam is an NSAID, and amlodipine is a calcium channel blocker used for hypertension. Similar to option C, there is no known significant interaction between these two medications that would lead to increased bleeding or bruising.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
A. "You will need to take an anticonvulsant of some type for your lifetime."
This statement may be accurate for some individuals with chronic or recurrent seizure disorders, but it is a generalization. The duration of anticonvulsant therapy varies from person to person, and some individuals may eventually be able to discontinue medication under the guidance of their healthcare provider.
B. "This medication should be taken until you haven't had a seizure for a month."
While seizure control is a factor in determining the duration of treatment, setting a specific timeframe (e.g., one month) may not be applicable to everyone. The decision to continue or discontinue anticonvulsant therapy is usually individualized and based on various factors, including the type of seizure disorder and the individual's response to treatment.
C. "Seizures are unpredictable and so is the duration of the treatment."
This is the best response. It acknowledges the variability in seizure disorders and the individualized nature of treatment duration. Seizure management is often an ongoing process that requires monitoring and adjustments based on the person's specific circumstances.
D. "You will only need to take it for a short period of time because anticonvulsants will cure the seizure disorder."
Anticonvulsants are typically used to manage and control seizures rather than cure the underlying seizure disorder. While some individuals may experience a period of seizure freedom and be able to discontinue medication, this is not true for everyone. The duration of treatment varies, and some individuals may require long-term or even lifelong therapy.
Correct Answer is C
Explanation
A. Bethanechol (Urecholine)
Bethanechol is a cholinergic agonist used to treat urinary retention. It is not indicated for Alzheimer's disease.
B. Albuterol (Proventil)
Albuterol is a bronchodilator used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It is not indicated for Alzheimer's disease.
C. Rivastigmine
Rivastigmine is a medication commonly used for the treatment of Alzheimer's disease. It belongs to a class of drugs called cholinesterase inhibitors, which work by increasing the levels of acetylcholine in the brain. This can help improve cognitive function in individuals with Alzheimer's disease.
D. Edrophonium (Enlon)
Edrophonium is a medication used for the diagnostic evaluation of Myasthenia Gravis. It is not used in the treatment of Alzheimer's disease.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.